Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Tacrolimus in Dermatitis, Atopic: CTRI/2026/03/106402 Clinical Landscape Report 2026
9 min read
Tacrolimus in Dermatitis, Atopic: CTRI/2026/03/106402 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/03/106402 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Isatuximab-IRFC in Relapse multiple myeloma: NCT07479979 Clinical Landscape Report 2026
9 min read
Isatuximab-IRFC in Relapse multiple myeloma: NCT07479979 Clinical Landscape Report 2026
18 September 2026
NCT07479979 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Apatinib Mesylate in Metastatic osteosarcoma: NCT07479732 Clinical Landscape Report 2026
9 min read
Apatinib Mesylate in Metastatic osteosarcoma: NCT07479732 Clinical Landscape Report 2026
18 September 2026
NCT07479732 clinical landscape for Metastatic osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Venetoclax in Acute Myeloid Leukemia: NCT07478991 Clinical Landscape Report 2026
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07478991 Clinical Landscape Report 2026
18 September 2026
NCT07478991 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
IASO-782 in Systemic Lupus Erythematosus: NCT07483346 Clinical Landscape Report 2026
9 min read
IASO-782 in Systemic Lupus Erythematosus: NCT07483346 Clinical Landscape Report 2026
18 September 2026
NCT07483346 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ocrelizumab in Multiple Sclerosis, Primary Progressive: NCT07483450 Clinical Landscape Report 2026
9 min read
Ocrelizumab in Multiple Sclerosis, Primary Progressive: NCT07483450 Clinical Landscape Report 2026
18 September 2026
NCT07483450 clinical landscape for Multiple Sclerosis, Primary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
Read →
JL-19001 in Non-Muscle Invasive Bladder Neoplasms: NCT07483970 Clinical Landscape Report 2026
9 min read
JL-19001 in Non-Muscle Invasive Bladder Neoplasms: NCT07483970 Clinical Landscape Report 2026
18 September 2026
NCT07483970 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Venetoclax in Relapsing acute myeloid leukemia: NCT07486726 Clinical Landscape Report 2026
9 min read
Venetoclax in Relapsing acute myeloid leukemia: NCT07486726 Clinical Landscape Report 2026
18 September 2026
NCT07486726 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Olutasidenib in Acute Myeloid Leukemia: NCT07486713 Clinical Landscape Report 2026
9 min read
Olutasidenib in Acute Myeloid Leukemia: NCT07486713 Clinical Landscape Report 2026
18 September 2026
NCT07486713 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
HBM7575 in Dermatitis, Atopic: NCT07488065 Clinical Landscape Report 2026
9 min read
HBM7575 in Dermatitis, Atopic: NCT07488065 Clinical Landscape Report 2026
18 September 2026
NCT07488065 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Adalimumab in Arthritis, Psoriatic: NCT07486843 Clinical Landscape Report 2026
9 min read
Adalimumab in Arthritis, Psoriatic: NCT07486843 Clinical Landscape Report 2026
18 September 2026
NCT07486843 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Metformin Hydrochloride in Plaque psoriasis: NCT07485764 Clinical Landscape Report 2026
9 min read
Metformin Hydrochloride in Plaque psoriasis: NCT07485764 Clinical Landscape Report 2026
18 September 2026
NCT07485764 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →